Inflammation-immune-nutrition biomarkers and PSA variability: A population-based study on the clinical potential of the CALLY index
{{output}}
Prostate cancer (PCa) is the second leading cause of cancer-associated mortalities worldwide. Prostate-specific antigen (PSA) testing is pivotal for screening for PCa, despite its limited specificity due to confounding factors such as inflammation and nutritio... ...
